We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva to Keep 180-Day Exclusivity on Generic Hypertension Drugs
Teva to Keep 180-Day Exclusivity on Generic Hypertension Drugs
March 30, 2010
Teva Pharmaceutical will maintain 180-day exclusivity for its generic versions of Merck’s hypertension drugs Hyzaar and Cozaar after the FDA reaffirmed
a court decision.